Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Capital Expenditures (2016 - 2022)

Jaguar Health (JAGX) has disclosed Capital Expenditures for 5 consecutive years, with -$1.1 million as the latest value for Q3 2022.

  • On a quarterly basis, Capital Expenditures changed N/A to -$1.1 million in Q3 2022 year-over-year; TTM through Jun 2023 was -$1.1 million, a N/A change, with the full-year FY2024 number at $16000.0, changed N/A from a year prior.
  • Capital Expenditures was -$1.1 million for Q3 2022 at Jaguar Health, down from $6000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $7000.0 in Q1 2020 to a low of -$1.1 million in Q3 2022.
  • A 4-year average of -$271868.2 and a median of $6263.5 in 2018 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 14.29% in 2021; the steepest drop was 14.29% in 2021.
  • Jaguar Health's Capital Expenditures stood at $6527.0 in 2018, then increased by 7.25% to $7000.0 in 2020, then decreased by 14.29% to $6000.0 in 2021, then plummeted by 18550.0% to -$1.1 million in 2022.
  • Per Business Quant, the three most recent readings for JAGX's Capital Expenditures are -$1.1 million (Q3 2022), $6000.0 (Q1 2021), and $7000.0 (Q1 2020).